A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer Dose Level – mg kg Median age (years) - Cladribine - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-01-22 10:42:40		A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer Dose Level – mg/kg Median age (years) Add to Reading List Source URL: posters.omed.s3.amazonaws.com Download Document from Source Website File Size: 691,25 KB Share Document on Facebook